The Pipeline
PredictGen™ products build on first generation pharmacogenomics containing primarily gene coding variants by incorporating non-coding, regulatory variants that impact more than 90% of drug response.
TECHNOLOGY
Phenomics Health patented PredictGen technology utilizes AI and machine learning to predict drug response phenotypes for patients based on their genetic, biological, demographic, clinical, sociological, and environmental characteristics. PredictGen provides highly accurate, reproducible, and personalized drug selection and dosing recommendations.
PIONEERING
Phenomics Health patented PredictGen technology utilizes AI and machine learning to predict drug response phenotypes for patients based on their genetic, biological, demographic, clinical, sociological, and environmental characteristics. PredictGen provides highly accurate, reproducible, and personalized drug selection and dosing recommendations.
UNIQUE
Unique attributes of biological networks, disease and drug response networks have now been discovered, including focused spatial clustering of drug and disease gene risk variants that can be used to weight and predict the selection of specific medications from a broad range of possible patient phenotypes.
Designed For You
PredictGen pharmacogenomic testing is an opportunity to improve the efficacy and safety of medication prescribing.
Over 3 million serious adverse drug reactions (ADRs), including deaths, occur each year in the United States. ADRs are responsible for nearly 2.2 million hospital admissions per year in the US, resulting in over 100,000 deaths, while costing society an amount equal to the costs of drug treatment.
Phenomics Health is the first precision medicine company to personalize medication treatment by combining advanced pharmacogenomic methods to predict the right drug and right dose for multiple medical conditions with direct pharmacometabolomic measurement of medications actually in a patient’s circulation to accurately determine patient polypharmacy, drug-drug interactions, and patient adherence.
Three Components of Phenomics Advanced Precision Medicine
Sociomics(SM)
Sociomics brand of services evaluate biopsychosocial and other risk factors associated with adverse cultural, environmental, acute or chronic trauma, neglect, abuse, behavior harmful to self or others, heightened or chronic stress resulting from adverse conditions, economic and community living conditions and other social factors affecting an individual’s emotional and physical health, disease risk, and response to medications for developing a treatment plan, improving healthcare services, supporting patient wellness, and improving medication treatments for patients. Evaluation of Sociomics is a component of Phenomics Health Precision Medicine Platform.